simulect
(basiliximab)Novartis Pharmaceuticals Corporation
Usage: Simulect® (basiliximab) is indicated for preventing acute organ rejection in renal transplantation, used alongside cyclosporine (modified) and corticosteroids. Its efficacy for preventing rejection in other solid organ transplants has not been established.